» Articles » PMID: 30654793

Improvement of Diabetic Wound Healing by Topical Application of Vicenin-2 Hydrocolloid Film on Sprague Dawley Rats

Overview
Publisher Biomed Central
Date 2019 Jan 19
PMID 30654793
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Impaired wound healing is a debilitating complication of diabetes that leads to significant morbidity, particularly foot ulcers. The risk of developing diabetic foot ulcers for diabetic patients is 15% over their lifetime and approximately 85% of limb amputations is caused by non-healing ulcers. Unhealed, gangrenous wounds destroy the structural integrity of the skin, which acts as a protective barrier that prevents the invasion of external noxious agents into the body. Vicenin-2 (VCN-2) has been reported to contain prospective anti-oxidant and anti-inflammatory properties that enhance cell proliferation and migration. Sodium Alginate (SA) is a natural polysaccharide that possesses gel forming properties and has biodegradable and biocompatible characteristics. Therefore, the objective of this study is to evaluate the effect of SA wound dressings containing VCN-2 on diabetic wounds.

Methods: Wounds were inflicted in type-1 diabetic-streptozotocin (STZ) induced male Sprague Dawley rats. Subsequently, relevant groups were topically treated with the indicated concentrations (12.5, 25 and 50 μM) of VCN-2 hydrocolloid film over the study duration (14 days). The control group was treated with vehicle dressing (blank or allantoin). Wounded tissues and blood serum were collected on 0, 7 and 14 days prior to sacrifice. Appropriate wound assessments such as histological tests, nitric oxide assays, enzyme-linked immunosorbent assays (ELISA) and immunoblotting assays were conducted to confirm wound healing efficacy in the in vivo model. One-way Analysis of Variance (ANOVA) was used for statistical analysis.

Results: Results showed that hydrocolloid film was recapitulated with VCN-2 enhanced diabetic wound healing in a dose-dependent manner. VCN-2 reduced pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α), mediators (iNOS and COX-2), and nitric oxide (NO) via the NF-κB pathway. Data suggests that the VCN-2 film facilitated healing in hyperglycemic conditions by releasing growth factors such as (VEGF and TGF-β) to enhance cell proliferation, migration, and wound contraction via the VEGF and TGF-β mechanism pathways.

Conclusions: This study's findings suggest that VCN-2 may possess wound healing potential since topical treatment with VCN-2 hydrocolloid films effectively enhanced wound healing in hyperglycemic conditions.

Citing Articles

Wound management, healing, and early prosthetic rehabilitation: Part 2 - A scoping review of physical biomarkers.

Williams-Reid H, Johannesson A, Buis A Can Prosthet Orthot J. 2025; 7(2):43716.

PMID: 39990247 PMC: 11844764. DOI: 10.33137/cpoj.v7i2.43716.


Wound management, healing, and early prosthetic rehabilitation: Part 1 - A scoping review of healing and non-healing definitions.

Williams-Reid H, Johannesson A, Buis A Can Prosthet Orthot J. 2025; 7(2):43715.

PMID: 39990241 PMC: 11844765. DOI: 10.33137/cpoj.v7i2.43715.


The Effects of Acidified Nitrite on Wound Healing in Streptozotocin-Induced Diabetic Mice.

Ghorbani M, Ghajari G, Jalali Kondori B Adv Biomed Res. 2024; 13:97.

PMID: 39717258 PMC: 11665162. DOI: 10.4103/abr.abr_115_24.


Advancements in diabetic foot ulcer research: Focus on mesenchymal stem cells and their exosomes.

Wu S, Zhou Z, Li Y, Jiang J Heliyon. 2024; 10(17):e37031.

PMID: 39286219 PMC: 11403009. DOI: 10.1016/j.heliyon.2024.e37031.


Effect of 3-hydrazinylquinoxaline-2-thiol hydrogel on skin wound healing process in diabetic rats.

Alamre J, Alkreathy H, Ali A, Alfadil A, Alghamdi S Sci Rep. 2024; 14(1):20005.

PMID: 39198630 PMC: 11358542. DOI: 10.1038/s41598-024-70849-x.


References
1.
Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S . Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol. 2000; 115(2):245-53. DOI: 10.1046/j.1523-1747.2000.00029.x. View

2.
Altavilla D, Saitta A, Cucinotta D, Galeano M, Deodato B, Colonna M . Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes. 2001; 50(3):667-74. DOI: 10.2337/diabetes.50.3.667. View

3.
ROBSON M, Steed D, Franz M . Wound healing: biologic features and approaches to maximize healing trajectories. Curr Probl Surg. 2001; 38(2):72-140. DOI: 10.1067/msg.2001.111167. View

4.
Szkudelski T . The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2002; 50(6):537-46. View

5.
Witte M, Barbul A . Role of nitric oxide in wound repair. Am J Surg. 2002; 183(4):406-12. DOI: 10.1016/s0002-9610(02)00815-2. View